(NP (NP (NP (NN Contribution)) (PP (IN of) (NP (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN Sp1))) (NN binding) (NNS motifs))) (PP (TO to) (NP (NP (DT the) (JJ replicative) (NN capacity)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))))) (: :)) (S (NP-SBJ-26 (NP (JJ distinct) (NNS patterns)) (PP (IN of) (NP (JJ viral) (NN growth)))) (VP (VBP are) (VP (VBN determined) (NP (-NONE- *-26)) (PP (IN by) (NP-LGS (NN T-cell) (NNS types))))) (. .)))
(S (S-ADV (NP-SBJ (-NONE- *)) (VP (VBG Starting) (PP (IN with) (NP (NP (DT a) (JJ replication-incompetent) (JJ molecular) (NN clone)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))) (, ,) (VP (VBG lacking) (NP (NP (PDT all) (DT the) (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN Sp1))) (NN binding) (NNS sites)) (ADJP (JJ present) (PP (IN in) (NP (DT the) (JJ native) (NP (NP (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-)))))))))))) (, ,) (NP-SBJ-27 (NP (NNS proviruses)) (VP (VBG containing) (NP (NP (VBN reconstructed) (NNS LTRs)) (PP (IN with) (NP (NP-COOD (NP (JJ individual) (NP (-NONE- *RNR*-100))) (CC or) (NP (NP (NNS combinations)) (PP (IN of) (NP (-NONE- *RNR*-100))))) (NP-100 (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN Sp1))) (NNS elements))))))) (VP (VBD were) (VP-COOD (VP (VBN generated) (NP (-NONE- *-27))) (CC and) (VP (VBN evaluated) (NP (-NONE- *-27)) (PP (IN for) (NP (PRP$ their) (NN capacity) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB produce) (NP (NN virus) (NN progeny)) (PP-TMP (VBG following) (NP (NN transfection-cocultivation))))))))))) (. .))
(S (NP-SBJ (NP (NN Virus) (NNS stocks)) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN from) (NP (DT these) (NNS experiments))))) (VP (VBD exhibited) (NP (NP (DT a) (NN continuum)) (PP (IN of) (NP (JJ replicative) (NNS capacities))) (PP (IN in) (NP (JJ different) (JJ human) (NN T-cell) (NNS types)))) (PP (VBG depending) (PP (IN on) (SBAR (WHNP-30 (WDT which) (NN element) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (S (NP-SBJ (-NONE- *T*-30)) (VP (VBD was) (ADJP-PRD (JJ present) (PP (IN in) (NP (DT the) (NN LTR)))))))))) (. .))
(S (PP (IN For) (NP (NN example))) (, ,) (PP (IN in) (NP (NP (NNS experiments)) (VP (VBG involving) (NP (NP (JJ proviral) (NNS clones)) (PP (IN with) (NP (NP (NNS LTRs)) (VP (VBG containing) (NP-COOD (NP (QP (CD one) (CC or) (CD two)) (NN NF-kappa) (NN B) (NNS elements)) (-LRB- -LRB-) (CC and) (NP (DT no) (NN Sp1) (NN binding) (NNS sites)) (-RRB- -RRB-))))))))) (, ,) (NP-SBJ-31 (NP (DT a) (NN hierarchy)) (PP (IN of) (NP (NP (JJ cellular) (NN permissivity)) (PP (TO to) (NP (NN virus) (NN replication))))) (PRN (-LRB- -LRB-) (S (NP-SBJ (JJ peripheral) (NN blood) (NNS lymphocytes)) (VP (JJ =) (NP-PRD (NP (NN MT4)) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (NP (NN H9)) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (NP (NN CEM)) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (NN Jurkat))))))))))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-31)))) (. .))
(SINV (PP-PRD-TPC-32 (IN Of) (NP (NN note))) (VP (VBD was) (PP-PRD (-NONE- *T*-32))) (NP-SBJ (NP (DT the) (VBN associated) (NN emergence)) (PP (IN of) (NP (JJ second-site) (NN LTR) (NNS revertants))) (SBAR (WHNP-33 (WDT which)) (S (NP-SBJ (-NONE- *T*-33)) (VP (VBD involved) (NP (NP (DT an) (NN alteration)) (PP (IN of) (NP (DT the) (NN TATA) (NN box)))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-101 (DT the) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN LTR)) (VP-COOD (VP (VBZ possesses) (NP (NP (JJ functional) (NN redundancy)) (SBAR (WHNP-34 (WDT which)) (S (NP-SBJ (-NONE- *T*-34)) (VP (VBZ ensures) (NP (NP (NN virus) (NN replication)) (PP (IN in) (NP (JJ different) (NN T-cell) (NNS types))))))))) (CC and) (VP (VBZ is) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-101)) (VP (VBG changing)))) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (JJ particular) (NN combination)) (PP (IN of) (NP (NP (JJ transcriptional) (NNS factors)) (ADJP (JJ present))))))))))))) (. .))
